Indoco Remedies Ltd shares jump 11.33% as SEBI takeover disclosure received
Why did Indoco Remedies Ltd shares jump today?
Indoco Remedies Ltd shares saw a significant upward movement today, with the stock price jumping 11.33%. As of 02:28 PM on Thursday, the share price stood at ₹257.4. This sharp rise is directly linked to a regulatory filing that has boosted investor confidence in the pharmaceutical company.
The reason for the surge is a disclosure made under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The filing reveals that Ms. Aditi M. Panandikar, along with other promoters and persons acting in concert (PAC) including Mr. Suresh G. Kare and Ms. Madhura Suresh Kare, have purchased 38,930 equity shares of the company from the open market. This acquisition signifies a strong vote of confidence from the company's key stakeholders.
Such open-market purchases by promoters are often viewed as a positive signal by the market. It indicates that the individuals with intimate knowledge of the company's operations believe the current share price is attractive and expect future growth. This insider buying activity has clearly driven bullish sentiment, leading to the double-digit percentage jump in the share price today.
What does Indoco Remedies Ltd do?
Indoco Remedies Ltd is a publicly listed company, with equity shares traded on the National Stock Exchange of India (Stock Code: INDOCO) and the Bombay Stock Exchange (Stock Code: 532612). A disclosure regarding the purchase of 38,930 equity shares from the open market has been made in compliance with SEBI regulations.
The disclosure was submitted by Aditi M. Panandikar on behalf of herself and Suresh G Kare, Aruna Suresh Kare, and Madhura Suresh Kare. This communication was directed to the listing departments of the respective stock exchanges and the company's compliance officer at its registered office in Mumbai.
Indoco Remedies Ltd Financials
In CroresBased on the provided data, Indoco Remedies Ltd demonstrated mixed financial performance. Revenue showed a modest sequential increase from ₹455.9 Crores in March 2026 to ₹466.22 Crores in June 2026, reflecting approximately 2.3% quarter-over-quarter growth. The profit trajectory was more notable, as the company shifted from a net loss of ₹21.64 Crores in March 2026 to a net profit of ₹64.99 Crores in June 2026, representing a significant improvement of ₹86.63 Crores. This turnaround indicates that the company moved from loss-making to profitable status within a single quarter.
Indoco Remedies Ltd Shareholding Pattern
Promoter holding stands at 58.86% of the total share capital. Foreign Institutional Investors (FIIs) hold 1.27% stake in the company, while Domestic Institutional Investors (DIIs) hold 17.68%. Public shareholders hold the remaining 22.04% stake in Indoco Remedies Ltd.
Indoco Remedies Ltd FAQs
Q: Why did Indoco shares jump 11.33% today?
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Aditi M Panandikar & Others. This corporate action caught investor attention, leading to increased trading activity in the stock.
Q: What is the shareholding pattern of Indoco Remedies Ltd?
As per the latest data, promoters hold 58.86% stake in Indoco Remedies Ltd, while FII holding stands at 1.27%. Domestic institutional investors hold 17.68%, and public shareholders account for 22.04% of the equity.
Q: What is the current stock price of Indoco Remedies Ltd?
Indoco Remedies Ltd shares are currently trading at ₹257.4, recording a gain of 11.33% from the previous close.
Q: What is the market capitalization of Indoco Remedies Ltd?
The company currently has a market capitalization of ₹2372.24 crore, reflecting its valuation in the Indian equity market.